Fiona provides senior scientific counsel and strategic leadership at Biosector 2. She brings a unique approach and invaluable insight to effectively communicating complex scientific information to various audiences, with experience covering a broad spectrum of healthcare communication programs in many therapy areas; global, pan-European, and UK-based. Fiona transitioned into healthcare communication from academia as a biomedical research scientist, collectively spanning over 19 years and has wide-ranging expertise in both medical education and public relations programs, including issues management and communication planning around regulatory milestones.
B2 is part of INC Research/inVentiv Health, an industry-changing new company, purpose-built to help the industry achieve a singular goal: Biopharmaceutical Acceleration. The coming together of two dedicated businesses allows us to address new market realities through clinical and commercial sharing expertise, data and insights to meet the needs of global biopharmaceutical companies of all sizes to speed the delivery of therapies to patients worldwide.